Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis
Management of oxaliplatin-induced peripheral neuropathy (OIPN) has proven challenging owing to the concern that any OIPN-preventing agents may also decrease the efficacy of the chemotherapeutic agent and fail to reverse established neuronal damage. Nevertheless, targeting redox signaling pathways co...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2020-09-01
|
| Colección: | Redox Biology |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S221323172030882X |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
